Function of the p97–Ufd1–Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains by Ye, Yihong et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 

 
 The Rockefeller University Press, 0021-9525/2003/07/71/14 $8.00
The Journal of Cell Biology, Volume 162, Number 1, July 7, 2003 71–84
http://www.jcb.org/cgi/doi/10.1083/jcb.200302169
 
JCB
 
Article
 
71
 
Function of the p97–Ufd1–Npl4 complex in 
retrotranslocation from the ER to the cytosol: 
dual recognition of nonubiquitinated polypeptide 
segments and polyubiquitin chains
 
Yihong Ye,
 
1
 
 Hemmo H. Meyer,
 
2
 
 and Tom A. Rapoport
 
1
 
1
 
Howard Hughes Medical Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115
 
2
 
Department of Cell Biology, Yale Medical School, New Haven, CT, 06520
 
member of the family of ATPases associated with
diverse cellular activities, called p97 in mammals
and Cdc48 in yeast, associates with the cofactor
Ufd1–Npl4 to move polyubiquitinated polypeptides from
the endoplasmic reticulum (ER) membrane into the cytosol
for their subsequent degradation by the proteasome. Here, we
have studied the mechanism by which the p97–Ufd1–Npl4
complex functions in this retrotranslocation pathway.
Substrate binding occurs when the ﬁrst ATPase domain of
p97 (D1 domain) is in its nucleotide-bound state, an inter-
action that also requires an association of p97 with the
 
membrane through its NH
 
2
 
-terminal domain. The two ATPase
domains (D1 and D2) of p97 appear to alternate in ATP
A
 
hydrolysis, which is essential for the movement of poly-
peptides from the ER membrane into the cytosol. The ATPase
itself can interact with nonmodiﬁed polypeptide substrates
as they emerge from the ER membrane. Polyubiquitin chains
linked by lysine 48 are recognized in a synergistic manner
by both p97 and an evolutionarily conserved ubiquitin-
binding site at the NH
 
2
 
 terminus of Ufd1. We propose a
dual recognition model in which the ATPase complex
binds both a nonmodiﬁed segment of the substrate and the
attached polyubiquitin chain; polyubiquitin binding may
activate the ATPase p97 to pull the polypeptide substrate
out of the membrane.
 
Introduction
 
The ER is the major site of protein folding and assembly in
the secretory pathway. Eukaryotic cells have evolved a highly
conserved ER quality control system that catalyzes protein
folding and prevents unfolded polypeptides or unassembled
protein complexes from reaching their final destinations (for
review see Ellgaard and Helenius, 2001). Misfolded or
unassembled polypeptides that cannot reach their native
conformation in the ER are retrotranslocated into the cytosol,
where  they are degraded by the proteasome, a pathway
termed ER-associated protein degradation, or retrotrans-
location (for reviews see Brodsky and McCracken, 1999; Tsai
et al., 2002). The mechanism of retrotranslocation is largely
unknown. However, recent works have shed some light on
the decisive step during which polypeptides are released
from the ER membrane into the cytosol before they are
degraded by the proteasome. The release step seems to require
an ATPase, named Cdc48 in yeast and p97 in mammals
(Bays et al., 2001; Ye et al., 2001; Braun et al., 2002; Jarosch
et al., 2002; Rabinovich et al., 2002).
p97/Cdc48 belongs to a family of ATPases associated with
diverse cellular activities (AAA;* for review see Ogura and
Wilkinson, 2001). The characteristic feature of this family is
the presence of one or two conserved ATPase domains, referred
to as AAA cassettes, which contain Walker A and Walker B
motifs that mediate ATP binding and hydrolysis, respectively.
p97/Cdc48 is similar to the NSF protein involved in vesicle
fusion in the secretory pathway. Like NSF, p97/Cdc48 con-
sists of two ATPase domains (D1 and D2) and an additional
NH
 
2
 
-terminal domain (N). Structural studies reveal that the
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ATPase domains form two hexameric rings stacked on top
of each other with a central pore of 
 
 
 
15 Å (Rouiller et al.,
2000; Zhang et al., 2000). The N domains are located at the
side of the D1 ring. Although both p97 and Cdc48 are
abundant cytosolic proteins, a significant fraction of them is
tightly associated with the ER membrane (Rabouille et al.,
1998; Hitchcock et al., 2001).
The ATPase p97/Cdc48 appears to perform different cel-
lular functions depending on its association with cofactors
(Meyer et al., 2000). Mammalian p97 can interact in a mu-
tually exclusive manner with either p47 or a dimer consist-
ing of Ufd1 and Npl4. In mammals, the complex of p97–
p47 appears to play a role in the homotypic fusion of ER
and Golgi membranes (Kondo et al., 1997; Rabouille et al.,
1998; Uchiyama et al., 2002). The p97–p47 complex binds
ubiquitinated proteins via a UBA domain in p47, and this
domain is essential for its activity in Golgi membrane fusion
(Meyer et al., 2002). In 
 
Saccharomyces cerevisiae
 
, the com-
plex of Cdc48–Ufd1–Npl4 has been implicated in the re-
lease of polypeptides from the ER membrane (for review see
Tsai et al., 2002). This release step is essential for both ret-
rotranslocation of misfolded proteins from the ER into the
cytosol, and for the activation of the transcription factor
Spt23 from its ER-anchored precursor (Hitchcock et al.,
2001; Rape et al., 2001). Mammalian p97 has also been
shown to function in retrotranslocation (Ye et al., 2001),
but a requirement for the cofactor Ufd1–Npl4 has not yet
been demonstrated.
Exactly how p97/Cdc48 and its cofactor Ufd1–Npl4 ex-
tract polypeptides from the ER membrane during ret-
rotranslocation is unclear. It is not known how the ATPase
binds to the ER membrane, nor how the two ATPase do-
mains collaborate to “pull” polypeptides out of the mem-
brane. The mechanism of substrate recognition has been
particularly difficult to address because its elucidation re-
quires complex systems in which p97/Cdc48 acts on physio-
logical substrates emerging from the ER membrane. Two
possibilities of substrate recognition have been proposed. In
one model, p97/Cdc48 would interact directly with an un-
folded polypeptide segment as it emerges from the ER mem-
brane. Alternatively, the recognition signal could be a poly-
ubiquitin chain attached to a substrate. This model is based
on the fact that all polypeptides emerging from the ER un-
dergo polyubiquitination, and that this modification is re-
quired for the release of substrates from the ER membrane
into the cytosol (for review see Tsai et al., 2002).
Mammalian Ufd1–Npl4 has been shown to bind poly-
ubiquitin and has been proposed to mediate substrate bind-
ing by p97 (Meyer et al., 2002). A zinc-binding motif in
Npl4, the Npl4 zinc finger (NZF) domain, has been identi-
fied as the major binding site for ubiquitin (Meyer et al.,
2002; Wang et al., 2003). In addition, p97/Cdc48 itself can
interact with ubiquitin (Dai and Li, 2001; Rape et al.,
2001). The relevance of the reported ubiquitin interactions
for retrotranslocation is unclear, particularly because the
ubiquitin binding to p97/Cdc48 is weak and the yeast ho-
mologue of Npl4 lacks an NZF domain.
In this paper, we have addressed the mechanism by which
the p97 ATPase and its cofactor Ufd1–Npl4 function in ret-
rotranslocation. Our results provide insight into the ATPase
cycle, the mode of interaction of the complex with the mem-
brane, and particularly the mechanism of substrate recogni-
tion. We propose a dual recognition mechanism in which a
nonubiquitinated segment of a substrate is initially recog-
nized by p97 itself, and subsequently, the polyubiquitin
chain is bound by both p97 and the cofactor Ufd1–Npl4.
 
Results
 
Coupling between the two ATPase domains of p97
 
p97 contains an NH
 
2
 
-terminal domain (N) and two AAA
cassettes (D1 and D2; Fig. 1 A). To understand how the two
ATPase domains of p97 influence one another, we generated
a set of point mutants that are defective in the ATPase cycle
of either one or both of the two domains. Mutants defective
in ATP binding were obtained by altering the lysine residue
(K) in the Walker A motifs to an alanine (A), resulting in
mutants in the D1 domain (AK mutant), D2 domain (KA
mutant), or in both domains (AA mutant). Mutants that al-
low ATP binding but are defective in hydrolysis were
obtained by mutating in the D1 and D2 domains the
conserved glutamate residue of the Walker B motifs to glu-
tamine, resulting in the QE, EQ, and QQ mutants. We also
generated deletion mutants that lack either the N domain
(
 
 
 
N) or the second ATPase domain (
 
 
 
D2). All these mu-
tants were expressed as His-tagged recombinant proteins in
 
Escherichia coli
 
 and purified (Fig. 1 B). The oligomeric state
of these proteins was determined by gel filtration (unpub-
lished data). All proteins formed stable hexamers, similar to
the wild-type protein. ATP-binding experiments confirmed
that the AA mutant had a low affinity for the nucleotide,
whereas the KA mutant bound about half the amount of nu-
cleotide as the wild-type protein (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200302169/DC1). Inter-
estingly, the AK mutant behaved similarly to the AA mu-
tant, indicating that nucleotide binding to the D1 ring is re-
quired for ATP binding to D2. As expected, the QQ protein
bound ATP, but did not hydrolyze it (Fig. S1).
Next, we analyzed the ATPase activity of the p97 mutants
(Fig. 1 C). Deletion of the N domain had no effect on ATP-
ase activity. The QE mutant had 
 
 
 
50% ATPase activity
compared with the wild-type protein, indicating that both
the D1 and D2 domains contribute to the overall ATPase
activity of p97. This is in contrast to the situation with the
homologous NSF protein in which the D2 domain is inac-
tive (Steel and Morgan, 1998). In agreement with the nucle-
otide-binding experiments, the two ATPase domains appear
to influence one another. ATPase activity in D2 required
nucleotide binding (but not hydrolysis) by the D1 domain
because the mutant AK, in contrast to QE, was inactive.
Thus, ATP binding to D1 is required to induce hydrolysis
in D2. On the other hand, ATPase activity in D1 required
nucleotide binding and hydrolysis in D2 because both the
KA and EQ mutants, as well as the deletion mutant 
 
 
 
D2,
were inactive. This result suggests that ADP binding to D2
is required for ATP hydrolysis in D1. Together, these data
suggest that the D1 and D2 rings alternate in ATP hydroly-
sis (see Discussion).
To test the role of the ATPase domains in D1 and D2 in
vivo, we made the QE and EQ mutations in Cdc48, theT
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yeast homologue of p97. The mutants were tested for com-
plementation of a 
 
cdc48
 
 temperature-sensitive strain at the
nonpermissive temperature (Fig. 1 D). When the mutants
were expressed under a gal promoter in the presence of ga-
lactose, no growth was seen at 37
 
 
 
C, in contrast to the re-
sults with the wild-type protein (Fig. 1 D, top right), al-
though the transgenes were expressed at similar levels (Fig.
S2). At permissive temperature (30
 
 
 
C), the EQ mutant ex-
erted a strong dominant-negative effect on cell growth,
whereas the effect of the QE mutant was much weaker (Fig.
1 D, top left). As expected, when the proteins were not ex-
pressed in the presence of glucose, the cells grew at 30
 
 
 
C,
but not 37
 
 
 
C (Fig. 1 D, bottom). These data show that ATP
hydrolysis in both ATPase domains is required for the func-
tion of the ATPase in vivo.
 
Cofactor and membrane interaction domains of p97
 
To test the interaction of p97 with its cofactors, purified
p97 variants were incubated with rat liver cytosol at high salt
to break endogenous complexes. After lowering the salt con-
centration, complexes were immunoprecipitated with anti-
bodies directed against the NH
 
2
 
-terminal His tag of p97.
The precipitates were analyzed by immunoblotting with an-
tibodies to Ufd1 and p47. With the exception of the 
 
 
 
N
protein, all p97 variants were able to interact with both
Ufd1–Npl4 and p47 (Fig. 2 A). The results show that the
binding of both cofactors requires the N domain of p97.
To determine which domain of p97 is required for its in-
teraction with the ER membrane, we added various p97
proteins to permeabilized astrocytoma cells. After incuba-
tion, the membranes were sedimented and washed. Bound
p97 protein was detected by immunoblotting with antibod-
ies to the His tag in p97. As a loading control, the samples
were also probed with antibodies to the ER membrane pro-
tein calnexin. Membrane binding was observed for all the
p97 mutants except for the 
 
 
 
N protein (Fig. 2 B). Binding
was abolished when the membranes were pretreated with
protease (unpublished data). These results show that the N
domain mediates not only the interaction with the cofactors,
but also the binding of p97 to the membrane.
Figure 1. ATPase activity of p97 mutants. (A) Scheme of p97 constructs 
used in this work (N, NH2-terminal domain; D1, D2, first and second 
ATPase domain, respectively). The name of each construct is shown on the 
left. For the wild-type protein (WT), the conserved lysine (K) in the Walker 
A motif and glutamate (E) in the Walker B motif are indicated. For the 
mutants, the alanine (A) or glutamine (Q) altered residue is shown. (B) The p97 
proteins were expressed in E. coli, purified, and subjected to SDS-PAGE. 
Shown is the gel after staining with Coomassie blue. (C) The ATPase activity 
of the different p97 proteins was measured. Shown is the mean of three 
experiments. (D) Wild-type Cdc48, the yeast homologue of p97, or ATP 
hydrolysis mutants (QE or EQ) were expressed under the gal promoter in 
the presence of galactose in the temperature-sensitive cdc48–3 yeast strain 
at the permissive (30 C) or nonpermissive (37 C) temperature (top). As control, 
the cells were grown on glucose to repress the genes (bottom).T
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Substrate interaction of p97
 
Next, we investigated the association of the p97 mutants
with a retrotranslocation substrate. The substrate chosen was
MHC class I heavy chain, which is targeted for retrotranslo-
cation and subsequent proteasomal degradation in cells ex-
pressing the human cytomegalovirus protein US11 (Wiertz
et al., 1996). The process can be recapitulated in permea-
bilized cells (Shamu et al., 1999). To determine binding
of p97 to MHC class I heavy chains, US11-expressing
cells were treated with proteasome inhibitors, labeled with
[
 
35
 
S]methionine, and permeabilized with the detergent digi-
tonin. His-tagged p97 variants were added, the cells were in-
cubated for a chase period, and then they were fractionated
into membrane (P) and cytosol (S) fractions. A portion of
the samples was subjected to immunoprecipitation with
heavy chain (HC) antibodies to monitor the amount of
substrate in each sample (Fig. 3, A–C, top panels). The re-
mainder of the samples was subjected to sequential immu-
noprecipitation with His and HC antibodies to detect
p97-associated heavy chains (Fig. 3, A–C, bottom panels).
Previous experiments provided evidence that association of
the exogenous p97 with heavy chains occurs during ret-
rotranslocation because (1) binding to p97 was seen preferen-
tially with heavy chains on the membrane; (2) the interaction
was reduced when the membranes were solubilized before ad-
dition of p97; and (3) no binding was seen with heavy chains
of cells that did not express US11 (Ye et al., 2001).
The p97 mutants defective in ATP hydrolysis (QQ, EQ,
and QE) interacted with heavy chains on the membrane, al-
though the QE mutant had lower affinity (Fig. 3 A, bottom,
lanes 5–16). The nucleotide-binding KA mutant, but not
the AK and AA proteins, also bound heavy chains (Fig. 3 B,
bottom, lanes 5–8 vs. lanes 1–4 and 9–12), suggesting that
ATP binding in D1 is required for substrate binding. As
might be expected from the lack of membrane interaction,
the 
 
 
 
N protein did not interact with substrate (Fig. 3 C,
bottom, lanes 5–8). Because the AK and AA proteins cannot
interact with substrate but still bind to membranes (Fig. 2
B), it appears that p97 binds to membranes not solely
through an interaction with substrate.
Next, we tested whether the mutant p97 proteins have a
dominant-negative effect on the retrotranslocation of MHC
class I heavy chains (Fig. 3 A–C, top panels). In the absence
of added p97 or in the presence of exogenous wild-type p97,
a significant fraction of the heavy chains was retrotranslo-
cated into the cytosol during the chase period (Fig. 3 A, top,
lane 4; Fig. 3 B, top, lane 16). The cytosolic heavy chains
have a slightly faster mobility in the SDS gel because they
are deglycosylated by a cytosolic 
 
N
 
-glycanase. Likewise, p97
mutants that were defective in substrate interaction (AK,
AA, and 
 
 
 
N) also did not affect retrotranslocation. In con-
trast, the p97 variants that allowed substrate binding but did
not permit ATP hydrolysis (EQ, QQ, KA, and 
 
 
 
D2; Fig. 1
C) strongly inhibited heavy chain dislocation; the amount of
deglycosylated heavy chains in the cytosol fraction (S) was
reduced, and the amount of glycosylated heavy chains in the
membrane fraction (P) was increased (Fig. 3, top). The D1
hydrolysis mutant QE, which had lower affinity to substrate
and had 
 
 
 
50% residual ATPase activity (Fig. 1 C), had a
weak effect on heavy chain retrotranslocation (Fig. 3 A, top,
lane 8 vs. lane 4 and lane 7 vs. lane 3; see also Fig. 4). These
data indicate that the dominant-negative effect of the p97
mutants is a consequence of sequestering heavy chains in a
defective ATPase complex.
These conclusions were confirmed when we directly tested
the dominant-negative effect of the p97 mutants on MHC
class I heavy chain degradation in the absence of proteasome
inhibitors (Fig. 4). Again, the mutants that allowed substrate
Figure 2. p97 binding to cofactors and membrane requires its 
N domain. (A) p97 binding to cofactors. Purified His-tagged p97 
proteins (His-p97) were added to rat liver cytosol in the presence 
of 1 M NaCl. After dilution of the salt to 150 mM, p97 was immuno-
precipitated with His antibodies. Bound proteins were detected 
by immunoblotting with antibodies to the indicated proteins. 
(B) Association of p97 with the membrane. Purified His-p97 proteins 
were added to permeabilized astrocytoma cells. After incubation, 
the cells were fractionated into membrane (P) and cytosol (S) fractions. 
The amount of His-p97 in each fraction was determined by immuno-
blotting with His antibodies (top). Immunoblotting for calnexin served 
as a loading control for the membrane fraction (bottom).T
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binding but had a low ATPase activity (EQ, QQ, KA, and
 
 
 
D2 mutants) inhibited retrotranslocation and stabilized the
substrate. In agreement with the in vivo results in yeast (Fig.
1 D), the QE mutant had a much smaller dominant-negative
effect than the EQ mutant. All mutants that failed to bind
heavy chains (AK, AA, and 
 
 
 
N) had no effect. Together,
these results show that membrane binding of p97 requires its
N domain, whereas substrate binding additionally requires
the D1 domain in its nucleotide-bound state; ATP hydroly-
sis by the D2 domain, and probably also the D1 domain, are
needed to move the polypeptide chain into the cytosol.
 
Ubiquitination is not required for substrate recognition 
by p97
 
Although the majority of the heavy chains bound to p97
were unmodified (Fig. 3, bottom), the results did not ex-
clude that they were originally polyubiquitinated when they
bound to p97 and were subsequently de-ubiquitinated by an
isopeptidase. De-ubiquitination must, in fact, be a very effi-
cient process because the heavy chains accumulating in the
cytosol in the presence of proteasome inhibitor are mostly
unmodified (Fig. 3 A, top, lane 4), despite the fact that they
must have been polyubiquitinated on the membrane (Shamu
et al., 2001). To test whether p97 can interact with heavy
chains that were never modified, the cytosol in permeabi-
lized US11 cells was replaced with ubiquitin-depleted cow
liver cytosol (Shamu et al., 2001). Pulse-chase experiments
showed that in the absence of ubiquitin, the heavy chains
were stable and remained in the ER membrane (Fig. 5 A,
lanes 6 and 7 vs. lanes 2 and 3). To test substrate binding of
p97, we added His-tagged p97 to permeabilized cells incu-
bated for different time periods in cytosol containing or lack-
ing ubiquitin, and performed sequential immunoprecipita-
tions with antibodies to the His tag and to the heavy chains.
In the absence of ubiquitin, a significant fraction of the heavy
chains was bound to p97 (Fig. 5 B, bottom, lanes 7–12). The
fraction increased during the chase incubation, indicating
that the movement of heavy chains from the ER lumen to
the cytoplasmic side of the ER membrane is independent of
ubiquitination. When purified ubiquitin was added back to
ubiquitin-depleted cytosol, an interaction of substrate with
p97 was only seen at early time points during the chase incu-
bation (Fig. 5 B, bottom, lanes 13–18); because ubiquitin re-
stored degradation of the heavy chains (Fig. 5 B, top), there
was little material left for interaction with p97 at later time
points. As expected, no material was immunoprecipitated
when His-tagged p97 was omitted from the incubation (Fig.
5 B, bottom, lanes 1–6). As expected from the previous re-
sults (Fig. 3), the QQ, but not the 
 
 
 
N and AA mutants of
p97, interacted with nonubiquitinated substrate (Fig. 5 C).
These data suggest that p97 can specifically interact with
substrate that has not been modified by a polyubiquitin
chain, and that binding of p97 is an early step after emer-
gence of the polypeptide from the ER.
 
Recognition of the polyubiquitin chain 
by the p97–Ufd1–Npl4 complex
 
Because the p97-dependent release of substrate from the
membrane requires polyubiquitination, we tested how the
polyubiquitin chain is recognized by p97 and its cofactor
Ufd1–Npl4. To address interactions between polyubiquitin
and the ATPase complex, we used polyubiquitin chains syn-
thesized in vitro using purified recombinant proteins. The
polyubiquitination reaction contained ubiquitin, the ubiq-
uitin-activating enzyme (E1), the ubiquitin-conjugating en-
Figure 3. Association of p97 with MHC class I heavy chains. Cells 
expressing the cytomegalovirus protein US11 were incubated 
with proteasome inhibitors and [
35S]methionine, and were then 
permeabilized in the presence of various purified His-p97 proteins. 
After incubation, samples were taken at different time points of the 
chase period and fractionated into membrane (P) and cytosol (S) 
fractions. A portion of the samples was subjected to immunoprecipi-
tation with heavy chain (HC) antibodies to monitor the amount of 
substrate in each sample (A–C, top). The remainder of the samples 
was subjected to sequential immunoprecipitation with His and HC 
antibodies to detect heavy chains bound to p97 (A–C, bottom). 
HC CHO and HC CHO indicate the glycosylated and deglyco-
sylated forms of the heavy chains, respectively.T
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zyme Ubc7 (E2), and a GST fusion to a cytosolic fragment
of the ubiquitin ligase gp78 (E3; the purity of the recombi-
nant E2 and E3 proteins is shown in Fig. 6 A, lanes 1 and 2).
We used Ubc7 and gp78 because both are known to be in-
volved in the degradation of at least some misfolded ER pro-
teins (Fang et al., 2001; Tiwari and Weissman, 2001). When
all components were incubated together in the presence of
ATP, ubiquitin conjugates consisting of 2 to 
 
 
 
40 ubiquitin
molecules were synthesized (Fig. 6 B, lane 4 vs. lanes 1–3).
The majority of chains are not associated with the E3 en-
zyme because they did not bind to glutathione beads with
the GST-gp78 protein (unpublished data). No polyubiquitin
chains were formed when wild-type ubiquitin was replaced
by methylated ubiquitin, in which all lysines are blocked, or
by the ubiquitin K48R mutant, which carries an arginine in-
stead of the lysine at position 48 (Fig. 6 C). Moreover, when
ubiquitin derivatives with single lysines at different positions
were tested, only the mutant with a lysine at position 48
(K48) gave efficient polyubiquitination (Fig. 6 D, lane 7).
These data show that polyubiquitin chains synthesized in
this system are linked through lysine 48, the same linkage re-
quired for protein degradation by the proteasome.
Then, we tested whether the cofactor Ufd1–Npl4 interacts
with these polyubiquitin chains. In vitro–synthesized poly-
ubiquitin chains were incubated with either the cofactor
complex Ufd1–Npl4 (U/N) or with the ternary complex
Ufd1–Npl4–His-p97 (U/N/p97). Antibodies to Ufd1 were
used to precipitate the complexes, and indeed brought down
all components, as demonstrated by immunoblotting with
different antibodies (Fig. 6 E, bottom). Bound ubiquitin
chains were detected by immunoblotting with anti-ubiquitin
antibodies (Fig. 6 E, top). Both the U/N and U/N/p97 com-
plexes efficiently bound polyubiquitin chains (Fig. 6 E, top,
lane 3 and lane 5). These data confirm the recent finding
that the cofactors provide a binding site for polyubiquitin
chains (Meyer et al., 2002). Interestingly, however, deletion
of the NZF domain of Npl4, the only known binding site
for polyubiquitin chains in the cofactor complex, reduced
(but did not abolish) the interaction (lane 4 vs. lane 3).
Thus, a hitherto unidentified polyubiquitin-binding domain
must exist in other portions of the Ufd1–Npl4 proteins.
To test the specificity of the ubiquitin interaction with the
cofactor Ufd1–Npl4, we used in vitro–synthesized polyubiq-
uitin chains with linkages through lysine 63 (K63). These
Figure 4. Effect of p97 mutants on MHC class I heavy chain degradation. US11-expressing cells were labeled and permeabilized in the 
presence of various purified His-p97 proteins. The samples were chase-incubated for different time periods and subjected to immuno-
precipitation with heavy chain (HC) antibodies. The graphs show the quantification of the experiments. Error bars in the bottom graph are 
derived from three experiments.T
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chains were synthesized with the yeast ubiquitin–conjugating
enzyme (E2) consisting of Ubc13 and Mms2 (Hofmann and
Pickart, 1999; the purity of the dimer is shown in Fig. 6 A,
lane 3). These polyubiquitin chains were also bound to both
the U/N and U/N/p97 complexes (Fig. 6 E, top, lane 8 and
 
lane 10). However, the lysine 63 chains were not bound
when the NZF domain was missing in Npl4 (Fig. 6 E, top,
lane 10; 
 
 
 
5% of the input material was bound). Thus, in
the absence of the NZF domain, the interaction of the
Ufd1–Npl4 complex with polyubiquitin chains is specific for
the lysine 48 linkage. The NZF domain, on the other hand,
appears to be promiscuous, and interacts with both lysine
48– and lysine 63–linked ubiquitin chains.
Because the yeast homologue of Npl4 lacks the NZF do-
main, one might expect that the yeast Cdc48–Ufd1–Npl4
complex interacts with lysine 48– but not lysine 63–linked
polyubiquitin chains. To test this possibility, we replaced the
wild-type Ufd1 protein in 
 
S. cerevisiae
 
 with a fusion of Ufd1
to an IgG-binding domain (Ufd1–PrA). The cells were ho-
mogenized and the Cdc48–Ufd1–Npl4 complex isolated by
binding to IgG beads. As expected, Cdc48 was bound to the
beads together with the tagged Ufd1 protein (Fig. 6 F, bot-
tom, lane 3 and lane 6). When incubated with in vitro–syn-
thesized polyubiquitin chains, the complex indeed bound
chains with lysine 48 linkage (Fig. 6 F, top, lane 3), but not
those with lysine 63 linkage (Fig. 6 F, lane 6). Because both
the yeast Cdc48–Ufd1–Npl4 complex and the mammalian
Ufd1–Npl4
 
 
 
ZF lacking the NZF domain discriminate be-
tween lysine 48 and lysine 63 linkages, these data suggest
that the unidentified ubiquitin-binding site in the Ufd1–
Npl4 complex may be the one relevant for the conserved
function in ER protein degradation.
Next, we determined that the novel binding site is con-
tained in Ufd1. A purified mammalian Npl4 protein lacking
the NZF motif (Npl4
 
 
 
ZF) did not bind ubiquitin chains in
the absence of Ufd1 (unpublished data), whereas a GST fu-
sion to full-length Ufd1 interacted with polyubiquitin chains
containing lysine 48 linkages (Fig. 7 B, lane 3). A GST fu-
sion to the NH
 
2
 
-terminal 215 residues of Ufd1 (UT3 do-
main; Fig. 7 A), which was predicted to contain a double 
 
 
 
barrel fold (Coles et al., 1999; Golbik et al., 1999), also
bound ubiquitin chains (Fig. 7 B, lane 4). On the other
hand, a GST fusion to the COOH-terminal UT6 domain
(Fig. 7 A), containing binding sites for both p97 and Npl4
(Hetzer et al., 2001), was inactive (Fig. 7 B, lane 5).
To test whether p97 can also bind polyubiquitin chains,
the His-tagged p97 was immobilized via a GST-UT6 frag-
ment before incubation with polyubiquitin chains. With
chains containing lysine 48 linkages, binding was indeed ob-
served (Fig. 7 C, lane 3 vs. lane 2). As with Ufd1, the inter-
action was not seen with lysine 63 linkages (Fig. 7 C, lanes
6–8). The AA mutant of p97, which is unable to recognize
substrate (Fig. 3), also bound polyubiquitin chains (Fig. 7
C, lane 4), indicating that substrate and ubiquitin binding
can be separated. Together, these data suggest that both p97
and Ufd1 can bind polyubiquitin chains.
The interactions of p97 and Ufd1 with polyubiquitin ap-
pear to be synergistic. When both components were immo-
bilized together, polyubiquitin binding was significantly
stronger than with either component alone (Fig. 7 D, lane 6
and 7 vs. lanes 3–5). A similarly strong binding was seen
when all three components (p97, Ufd1, and Npl4
 
 
 
ZF)
were together in a ternary complex (Fig. 7 E, lane 7). These
interactions are again specific for lysine 48–linked poly-
ubiquitin chains (Fig. 7 E, lanes 1–7 vs. lanes 8–14). To-
Figure 5. p97 binds to heavy chains that were not ubiquitinated. 
(A) US11-expressing cells were labeled and permeabilized. The 
cytosol was removed by high speed centrifugation and replaced 
with cow liver cytosol that was ubiquitin depleted ( Ub). Where 
indicated, purified ubiquitin was added back to the depleted cytosol 
( Ub). After chase incubation, the samples were either analyzed 
directly by immunoprecipitation with heavy chain (HC) antibodies 
(T), or first fractionated into membrane (P) and cytosol (S) fractions 
before immunoprecipitation with HC antibodies. (B) Purified His-p97 
was added during the permeabilization of labeled cells. A portion of 
the membrane and cytosol fractions was subjected to immuno-
precipitation with HC antibodies (top), and the rest was analyzed by 
sequential immunoprecipitation with His and HC antibodies (bottom). 
(C) Astrocytoma cells stably expressing hemagglutinin (HA)-tagged 
MHC class I heavy chains were permeabilized and incubated with 
ubiquitin-depleted cytosol in the presence of purified wild-type 
His-p97 or the indicated His-tagged mutant proteins. The membrane 
fraction was subjected to immunoprecipitation with HA antibodies (top) 
or His and HA antibodies (bottom). Note that the increase in the 
amount of p97-associated, HA-tagged heavy chains is less apparent 
than that in B, which may result from heavy chain overexpression.T
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Figure 6.
 
Ubiquitin recognition by the p97–Ufd1–Npl4 complex.
 
 (A) A GST fusion to the cytosolic fragment of the ubiquitin ligase gp78, 
the ubiquitin-conjugating enzyme Ubc7, and the ubiquitin-conjugating complex consisting of the Ubc13 and Mms2 were all expressed 
in 
 
E. coli
 
 and purified. Shown is a Coomassie-stained gel after SDS-PAGE with mol wt markers on the right side. (B) In vitro ubiquitination 
reactions were performed with the indicated components in the presence of ubiquitin activation enzyme (E1) and ATP. The samples were 
analyzed by immunoblotting with ubiquitin antibodies. Ub, Ub2, and Ub(n) indicate the positions of ubiquitin, di-ubiquitin, and polyubiquitin 
chains, respectively. (C) Shown is a comparison of wild-type ubiquitin (Ub) with methylated ubiquitin (Ub-m) and a mutant ubiquitin carrying 
a substitution of lysine 48 by arginine (UbK48R). The reactions were performed as in B. (D) Ubiquitin mutants with single lysines at the indicated 
position were tested in reactions similar to those in B. (E) Polyubiquitin chains were synthesized with either Ubc7/GST-gp78c (lanes 1–5) or 
Ubc13/Mms2 (lanes 6–10), generating chains with lysine 48 and lysine 63 linkages, respectively. These chains were incubated with the 
indicated proteins, and the samples were subjected to immunoprecipitation with Ufd1 antibodies (lanes 2–5 and lanes 7–10). Bound ubiquitin 
chains were detected by immunoblotting with ubiquitin antibodies (Ub; top). A portion of the immunoprecipitates was analyzed by immuno-
blotting with His (middle) or Ufd1 and Npl4 antibodies (bottom). UbK48 and UbK63 indicate chains with lysine 48 and lysine 63 linkages, 
respectively. (F) Yeast cytosol from a control strain (UFD1) or a strain expressing protein A–tagged UFD1 (UFD1
 
PrA
 
) was incubated with IgG T
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gether, our data suggest that the Ufd1–Npl4 complex has
an evolutionarily conserved function in mediating ubiq-
uitin binding of the ATPase complex. The Ufd1–Npl4–
p97 complex contains two conserved and cooperating poly-
ubiquitin-binding sites, one in p97 itself, and one in the
UT3 domain of Ufd1; the mammalian complex also con-
tains the NZF domain that may further increase the bind-
ing of polyubiquitin.
 
beads. The beads were incubated with in vitro–synthesized polyubiquitin chains, and the bound material was analyzed by immunoblotting 
with ubiquitin antibodies (top) and Cdc48 antibodies (bottom).
Figure 7. Polyubiquitin binding to p97 
and Ufd1. (A) Scheme of Ufd1 and mutant 
constructs used in the binding assays. 
The black box indicates the double   
barrel domain. The shaded box shows 
the p97- and Npl4-binding domain UT6. 
(B) Polyubiquitin chains synthesized 
with Ubc7/GST-gp78c were added to 
glutathione beads containing bound GST 
fusions to full-length Ufd1 or fragments 
of it. The bound fraction was analyzed 
by immunoblotting with ubiquitin and 
GST antibodies (top and bottom panels, 
respectively). The stars in the bottom 
panel indicate degradation products of 
GST-UT6. (C) A GST fusion to the UT6 
domain was immobilized on glutathione 
beads in the absence (no p97) or presence 
of His-tagged wild-type p97 or AA mutant. 
Binding of polyubiquitin chains with 
lysine 48 linkages was tested as in B. 
Bound proteins were also analyzed by 
immunoblotting with p97 (middle) or 
GST (bottom) antibodies. As a control, 
binding of polyubiquitin chains with 
lysine 63 linkages was tested (lanes 5–8). 
(D) GST fusions to the UT6 domain or 
Ufd1 were immobilized on glutathione 
beads in the absence (no p97) or presence 
of excess untagged or His-tagged p97. 
Polyubiquitin binding was analyzed as 
in C. (E) GST fusions to the UT6 fragment 
and Ufd1 were immobilized in the 
presence of p97 or p97 plus Npl4 lacking 
the NZF domain (Npl4 ZF). Polyubiquitin 
binding was tested as in D. Lanes 8–14 
show controls with lysine 63–linked 
polyubiquitin chains.T
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The ubiquitin-binding domain of Ufd1 is required 
for retrotranslocation
 
Next, we tested whether the ubiquitin-binding domain in
Ufd1 is important for the dislocation and degradation of
MHC class I heavy chains. We reasoned that a mutant
Ufd1–Npl4 complex lacking the UT3 ubiquitin-binding site
would act as a dominant-negative mutant by sequestering
endogenous p97 in a defective complex that could no longer
efficiently interact with ubiquitin chains on the substrate. In-
deed, although addition of either wild-type Ufd1–Npl4 (U/N)
or Ufd1–Npl4
 
 
 
ZF (U/N
 
 
 
ZF) had no effect on heavy
chain degradation (Fig. 8 A, top; for quantification, see top
right panel), the corresponding complexes lacking the UT3
domain (U
 
 
 
UT3/N and U
 
 
 
UT3/N
 
 
 
ZF) were inhibitory
(Fig. 8 A, bottom). Because all complexes tested bind p97
with similar affinity (unpublished data), the results suggest
that lack of ubiquitin interaction may cause the dominant-
negative effect. With the mutant lacking UT3 (Ufd1
 
 
 
UT3/
Npl4), polyubiquitinated heavy chains accumulated on the
membrane (Fig. 8 B, bottom, lane 11 vs. lane 3), as they did
when the ATPase mutant KA was added (Fig. 8 B, lane 7;
quantification given above the lanes). In controls, the ubiq-
uitinated heavy chains were released into the cytosol (Fig. 8
B, lane 4). Thus, both ubiquitin binding and ATP hydrolysis
by p97–Ufd1–Npl4 complex are required for the release
of polyubiquitinated substrates into the cytosol. Ubiquitin
binding to UT3, and not to the NZF domain of Npl4, ap-
pears to be important for retrotranslocation.
 
Discussion
 
Our results shed light on how the AAA ATPase p97 func-
tions together with its cofactor Ufd1–Npl4 in protein ret-
rotranslocation. One conclusion from the study of different
mutants is that the two ATPase domains of p97 are func-
tionally coupled. The activity of the second ATPase domain
(D2) requires nucleotide binding, but not hydrolysis by the
first ATPase domain (D1), indicating that the D2 domain
may hydrolyze nucleotides when D1 is in its ATP-bound
state. It appears that D2 can only bind ATP when D1 is in
its nucleotide-bound state. In contrast, the ATPase activity
of D1 depends on both ATP binding and hydrolysis by the
D2 domain, suggesting that the D1 domain likely hydrolyzes
ATP when D2 is in its ADP-bound form. Therefore, we pro-
Figure 8. The UT3 domain of Ufd1 is required for 
retrotranslocation. (A) US11-expressing cells were 
labeled and permeabilized in the presence of different 
Ufd1–Npl4 (U/N) variants. The added U/N complexes 
included wild-type U/N or U/N lacking either the NZF 
domain in Npl4 (U/N ZF), the UT3 domain in Ufd1 
(U UT3/N), or both the NZF domain and the UT3 
domains (U UT3/N ZF). After incubation for the 
indicated time periods, the samples were analyzed by 
immunoprecipitation with heavy chain (HC) antibodies. 
The graphs show the quantification of the experiments. 
(B) Comparison of the dominant-negative effects of the 
p97 ATPase mutant KA and of the cofactor complex 
U UT3/N. The experiment was performed as in A, but 
proteasome inhibitors were included during incubation. 
The samples were analyzed both directly (T) and after 
fractionation into membrane (P) or cytosol (S) fractions. 
A portion of the precipitated HC was subjected to a 
second round of immunoprecipitation with ubiquitin 
(Ub) antibodies (bottom). Quantification of the poly-
ubiquitin chains is given above the lanes, with the 
results in lane 2 set to 100%.T
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pose an ATPase cycle in which there is alternate ATP hydrol-
ysis in the two ATPase rings (Fig. 9 A). In this model, ATP
hydrolysis in D2 precedes that in D1. Conformational
changes consistent with this proposal have been observed
(Rouiller et al., 2002). Previous results had suggested that the
D1 domain does not hydrolyze ATP (Song et al., 2003), but
our results both in vitro and in yeast cells indicate that activ-
ity of D1 is required for the function of the protein. The pre-
vious results may perhaps be explained by the use of a differ-
ent mutation in the active site of D1 (K to T mutation).
Also, we have shown that substrate binding by p97 re-
quires D1, but not D2, to be in a nucleotide-bound state.
Other ATPases (such as GroEL/S, Hsp70, or ClpA) also re-
quire ATP binding, but not hydrolysis, for substrate binding.
In fact, the proposed alternate hydrolysis in the two ATPase
rings of p97 is reminiscent of the mechanism of GroEL/S
(for review see Bukau and Horwich, 1998). Another AAA
ATPase, Hsp104, also displays a similar communication be-
tween the two ATPase rings (Cashikar et al., 2002).
We propose that the polypeptide substrate is transported
through the central pore in the double barrel structure of
p97 in the direction of the D1 to the D2 ring. Our data in-
deed suggest that the D1 ring is proximal to the membrane
because the N domain, located at its side, is required for
membrane interaction of p97. However, because the N do-
main is also involved in cofactor binding, it is unclear which
component makes direct contact with the membrane. Be-
cause a mutant of p97 defective in substrate binding could
still bind to the membrane, substrate binding cannot be the
only linkage of the ATPase complex with the membrane. An
interaction with an unidentified membrane receptor may ex-
plain why a large fraction of p97 and of its yeast homologue
Cdc48 is firmly bound to the ER.
Our results provide insight into how the p97–Ufd1–Npl4
complex recognizes retrotranslocation substrates. p97 itself
recognizes both polyubiquitinated and nonubiquitinated
polypeptides. The strongest evidence that p97 can interact
with nonmodified substrate comes from our experiments in
which polyubiquitination was prevented. Because p97 bind-
ing to nonmodified substrate was similarly observed in a
crude permeabilized cell system in the presence of ubiquitin,
the interaction is not caused by ubiquitin depletion and is of
physiological relevance. Although direct contact of p97 with
substrate remains to be demonstrated, our data show that
the interaction is nucleotide dependent, as observed for
other ATPases (for review see Bukau and Horwich, 1998;
Figure 9. ATPase cycle and substrate recognition of p97. (A) Proposed communication between the two ATPase rings (D1 and D2) of p97. 
The D2 domain hydrolyzes ATP (T) and releases an orthophosphate (Pi), first converting the ring into its ADP-bound state (D). ATP hydrolysis 
in D1 follows. (B) A dual recognition model for p97–Ufd1–Npl4 function in retrotranslocation. Protein retrotranslocation is proposed to proceed 
in four steps. (I) A polypeptide chain emerging from the ER may be able to slide back and forth through the membrane (arrows), probably 
through a protein-conducting channel. The p97–Ufd1–Npl4 complex is recruited to the membrane by an unknown receptor (green). (II) A 
nonubiquitinated substrate is initially recognized by p97 (the ATPase domains D1 and D2 are shown in yellow, the N domain in blue). This 
interaction may prevent the substrate from backsliding into the ER lumen. The substrate also undergoes ubiquitination (red) at the membrane. 
(III) Once the ubiquitin chain (red) reaches a certain length, it interacts with p97 and the cofactor complex Ufd1–Npl4 (black). (IV) p97 uses 
ATP hydrolysis to move the polypeptide into the cytosol.T
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Hoskins et al., 2000). An appealing possibility is that p97
recognizes unfolded hydrophobic polypeptide segments as
demonstrated with model substrates (Thoms, 2002). The
VAT protein, a homologue of p97 in archaebacteria, must
also recognize nonubiquitinated substrates, because no ubiq-
uitination exists in these organisms.
In a pulse-chase experiment, the amount of p97-associ-
ated substrate increased with time when ubiquitination was
abolished, suggesting that p97 may interact with nonmodi-
fied polypeptides as soon as they emerge from the ER mem-
brane, preventing their backsliding into the ER lumen (Fig.
9 B). Although it has been proposed that ubiquitin mediates
the initial interaction of the transcription factor Spt23 with
the Cdc48–Ufd1–Npl4 complex (Rape et al., 2001), bind-
ing to an unfolded segment of the polypeptide has not been
excluded. At least for retrotranslocation substrates, it is likely
that polyubiquitination succeeds substrate binding to p97.
Our data suggest that the polyubiquitin chain is recog-
nized by both p97 and the cofactor Ufd1–Npl4. The find-
ing that p97 can weakly interact with polyubiquitin chains
is in agreement with previous results (Dai and Li, 2001;
Rape et al., 2001). The interaction of p97 with ubiquitin
appears to be distinct from that with nonmodified sub-
strate because it can be observed with the AA mutant of
p97 that is defective in substrate binding. Polyubiquitin
binding to the Ufd1–Npl4 complex was previously as-
cribed to the NZF domain of Npl4 (Meyer et al., 2002).
With a more sensitive binding assay, we now demonstrate
that the UT3 domain of Ufd1 contains an additional ubiq-
uitin-binding site that has a lower affinity than the NZF
domain, but appears to be more important for retrotrans-
location. This domain is similar in sequence among all
eukaryotic Ufd1 proteins, consistent with a conserved
function in retrotranslocation, and a cofactor complex
lacking this domain acts as a dominant-negative mutant in
retrotranslocation. These data also demonstrate that the
mammalian cofactor Ufd1–Npl4, like its homologue in
yeast, plays a role in ER protein degradation. The UT3 do-
main recognizes polyubiquitin chains in a lysine 48 (but
not lysine 63) linkage, as might be expected from the simi-
lar preference by the proteasome acting downstream of
p97 in the ER degradation pathway. Longer polyubiquitin
chains are the preferred substrate for Ufd1, in agreement
with our previous finding that a certain chain length is re-
quired for substrate release from the membrane (Shamu et
al., 2001). Whether the ubiquitin-binding NZF domain of
Npl4 plays a role in retrotranslocation is unclear because it
is missing in the yeast protein, does not show specificity for
the ubiquitin linkage, and because a mammalian cofactor
complex lacking this domain is not dominant negative. It
could play a supporting role in ER protein degradation in
mammalian cells, or could be involved in p97–Ufd1–Npl4
dependent processes other than retrotranslocation.
Our data suggest that p97 and Ufd1 act synergistically in
polyubiquitin binding. One possibility is that the proteins
together form a binding site with higher affinity. Specifi-
cally, double 
 
 
 
 barrel folds are present in both the UT3 do-
main of Ufd1 and the N domain of p97 (Coles et al., 1999;
Golbik et al., 1999), and these could both bind weakly to
polyubiquitin chains containing lysine 48 linkages. When
present together in a complex, the simultaneous interaction
of the double 
 
 
 
 barrel folds with polyubiquitin chains could
increase the affinity.
On the basis of our results, we propose a model of dual
substrate recognition by the p97–Ufd1–Npl4 complex; a
nonubiquitinated, unfolded segment of a retrotranslocation
substrate would initially be recognized by p97 itself (Fig. 9
B). Once a polyubiquitin chain has been attached to the
substrate, it would be recognized by both p97 and the cofac-
tor Ufd1 in the complex. This interaction may activate the
ATPase to pull the polypeptide chains out of the membrane.
Purified p97 has a relatively high intrinsic ATPase activity,
and therefore stimulation of the ATPase activity may require
that the basal activity in the cell be inhibited, perhaps by the
membrane receptor of p97. In the cytosol, the basal ATPase
activity of p97 is inhibited by the cofactor p47 (Meyer et al.,
1998). Consistent with our model, mutants in the p97–
Ufd1–Npl4 complex that can bind the substrate, but either
lack ubiquitin interaction or are defective in the ATPase cy-
cle, are dominant negative for retrotranslocation. The dual
recognition model explains why p97 interacts with nonubiq-
uitinated substrates and why polyubiquitination is neverthe-
less required for its function. The unmodified segments of
the polypeptide chain may be inserted as a loop into the cen-
tral cavity of the p97 double barrel, whereas the bulky poly-
ubiquitin chains may stay bound at the side of the barrel.
Loop insertion of a substrate polypeptide is also discussed
for the proteasome (Liu et al., 2003).
 
Materials and methods
 
Constructs
 
To generate the ATP hydrolysis mutants, codons E305 and/or E578 in plas-
mid pQE-p97 (Meyer et al., 2000) were mutated to Q. The ATP-binding
mutants were generated by changing codons K251 and/or K524 to A. The
 
 
 
N and the 
 
 
 
D2 constructs carry deletions of the NH
 
2
 
-terminal 185 resi-
dues or the COOH-terminal 348 residues, respectively. Plasmids encoding
mammalian Npl4, a construct lacking the NZF domain (Npl4
 
 
 
ZF),
COOH-terminally His-tagged Ufd1, and GST fusions to Ufd1, UT3, and
UT6 were all described previously (Meyer et al., 2000, 2002). UT3-HIS
was derived from pET–Ufd1–His by deleting the UT6 coding segment; His-
UT6 was generated by cloning the UT6 coding DNA segment into pTrcHis
(Invitrogen). The plasmids pGEX-gp78c and pGEX-MmUBC7 were pro-
vided by A. Weissman (National Cancer Institute, Bethesda, MD). Genes
coding for yeast Ubc13 and Mms2 were amplified by PCR from yeast ge-
nomic DNA and cloned into the pTrcHis-TOPO
 
®
 
 vector (Invitrogen).
Wild-type Cdc48 was cloned into pYC2NT (Invitrogen), and amino acids
E315 and E588 were altered to Q.
 
Antibodies, chemicals, and proteins
 
Antibodies to MHC class I heavy chain, ubiquitin, and the His tag have
been described previously (Ye et al., 2001). Antibodies to mammalian
Ufd1, Npl4, and p47 were described by Meyer et al. (2000). The Cdc48
antibodies were a gift from M. Latterich (McGill University, Montreal, Can-
ada). Calnexin and GST antibodies were purchased from StressGen Bio-
technologies and Amersham Biosciences, respectively; proteasome inhibi-
tor MG132 was purchased from Calbiochem; bovine ubiquitin was
purchased from Sigma-Aldrich; and ubiquitin K48R, methylated ubiqui-
tin, and ubiquitin activating enzyme (E1) was purchased from Affinity
BioReagents, Inc.
 
Protein purification
 
His-tagged proteins were all purified using Ni-NTA beads (QIAGEN). With
the exception of p97 variants, all proteins eluted from the Ni column were
further fractionated on a Mono-Q column using a 0–500-mM potassium
chloride gradient. The p97 variants were further purified by size-exclusion
chromatography on a Superdex™ 200 HR (10/30) column in 50 mM Tris/T
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HCl, pH 8.0, 150 mM potassium chloride, 5% glycerol, and 2 mM magne-
sium chloride. The complex of His-Ubc13/His-Mms2 was assembled on
the same size-exclusion column using the same conditions. GST-gp78c
and GST-Ubc7 were purified with glutathione beads. GST-gp78c was
eluted with reduced glutathione, whereas Ubc7 was cleaved off from the
beads using thrombin. The eluted proteins were further purified on a
Mono-Q column. The purification of GST-Ufd1, GST-UT3, GST-UT6,
Npl4, Npl4 ZF, Ufd1-His, UT3-His, and His-UT6, as well as the assembly
of various Ufd1–Npl4 complexes was described previously (Meyer et al.,
2002). His-UT6 and Npl4 as well as His-UT6 and Npl4 ZF were coex-
pressed in E. coli and purified on Ni-NTA. All purified proteins were stored
at  80 C in 50 mM Tris/HCl, pH 8.0, 150 mM potassium chloride, 2 mM
magnesium chloride, and 5% glycerol.
ATPase measurements, nucleotide and cofactor binding, and 
membrane association
The ATPase activity of p97 variants was measured as described previously
(Meyer et al., 1998). To test nucleotide binding by the p97 variants, 100  g
proteins were incubated with 0.2 mM ATP plus 2  Ci  [
32P]ATP in 50 mM
Tris/HCl, pH 8.0, 150 mM KCl, 1 mM magnesium chloride, and 15% glyc-
erol at 4 C for 20 min, and fractionated by a gel filtration column (NAP5;
Amersham Biosciences). Nucleotides in each fraction were analyzed by
TLC. The cofactor-binding assay was performed as before with slight modi-
fication (Meyer et al., 2000). 2- g purified His-tagged p97 proteins were
added to 500  g rat liver cytosol in 1 M NaCl, 50 mM Hepes, pH 7.6, 250
mM sucrose, 50 mM potassium acetate, 6 mM magnesium chloride, 1 mM
EDTA, and 1 mM DTT plus protease inhibitor. The salt concentration was
adjusted to 150 mM with 20 mM Hepes, pH 7.6 and 1 mM DTT. p97 pro-
teins were immunoprecipitated with His antibodies, and the bound proteins
were analyzed by immunoblotting with p47, Ufd1, and His antibodies. For
membrane-binding experiments, US11 cells were permeabilized with
0.028% digitonin in the presence of various p97 proteins at a concentration
of 1  M. After incubation, the membranes were sedimented and washed
with permeabilization buffer without detergent (25 mM Hepes, pH 7.3, 115
mM potassium acetate, 5 mM sodium acetate, 2.5 mM magnesium chlo-
ride, and 0.5 mM EGTA). Proteins in the membrane and cytosol fractions
were solubilized in sample buffer and analyzed by immunoblotting.
Dislocation and degradation of heavy chains 
and substrate binding
The experiments were performed as described previously (Ye et al., 2001).
Recombinant proteins were added at a 1- M concentration. Immunopre-
cipitation with heavy chain antibodies and reprecipitation with ubiquitin
antibodies were done as described previously (Shamu et al., 1999). The in-
teraction of p97 with MHC heavy chains was analyzed as described previ-
ously (Ye et al., 2001). Ubiquitin depletion experiments were performed as
described previously by incubating cow liver cytosol with a GST fusion to
a mutant of the ubiquitin-conjugating enzyme Ubc2B, which carries a Ser
instead of a Cys in the active site (Shamu et al., 2001).
In vitro ubiquitination and ubiquitin binding
Polyubiquitin chains were synthesized at 37 C with either 4  M Ubc7,
1 M GST-gp78c, or 2  M His-Ubc13/His-Mms2 in buffers containing 25
mM Tris/HCl, pH 7.4, 2 mM magnesium/ATP, 0.1 mM DTT, 110 nM E1
enzyme, and 20  M ubiquitin. The binding experiments were performed
at 4 C in 0.3 ml of 50 mM Hepes, pH 7.3, 150 mM potassium chloride,
2.5 mM magnesium chloride, 5% glycerol, 2 mM  -mercaptoethanol,
0.1% Triton X-100, and 1 mg/ml BSA. 20- l polyubiquitin chains were in-
cubated with 1  g of the various purified recombinant proteins. The pro-
teins were then precipitated with specific antibodies, and bound ubiquitin
chains were detected by immunoblotting with ubiquitin antibodies. To test
ubiquitin chain binding to GST fusion proteins, the latter were first immo-
bilized on glutathione beads. The ubiquitin chains were preabsorbed with
glutathione beads to remove the E3 and ubiquitin chains associated with it,
before addition to the immobilized proteins. To test ubiquitin binding of
the yeast Cdc48–Ufd1–Npl4 complex, the endogenous gene for Ufd1 was
replaced by a gene coding for a fusion of Ufd1 with the IgG-binding do-
main of protein A. Cytosol from the mutant yeast cells was incubated with
IgG beads to isolate the Cdc48–Ufd1–Npl4 complex, and was then incu-
bated with polyubiquitin chains.
Experiments with yeast
The yeast cdc48–3 strain was transformed with vector or plasmids coding
for either wild-type Cdc48 or mutant Cdc48 proteins. The cells were seri-
ally diluted and plated on galactose- or glucose-containing agar. They
were incubated at 30 or 37 C for 3 d.
Online supplemental material
Fig. S1 shows nucleotide binding to various His-tagged p97 proteins,
and Fig. S2 shows that mutant Cdc48 defective in ATP hydrolysis is ex-
pressed at similar levels as the wild-type protein in S. cerevisiae. Online
supplemental material available at http://www.jcb.org/cgi/content/full/
jcb.200302169/DC1.
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